AstraZeneca-Bristol drug just as effective as generic on market, trial results show
STOCKHOLM An investigational diabetes drug works as well as a generic already on the market, according to results of a late-stage clinical trial announced Friday by AstraZeneca and Bristol-Myers Squibb.
The two companies said phase-3 trial results showed that their investigational drug dapagliflozin combined with the widely available generic metformin was as effective as glipizide combined with metformin, compared with metformin alone. In addition, patients in the dapagliflozin group experienced weight loss, compared with weight gain in those taking glipizide, as well as a reduced number of patients experiencing abnormally low blood sugar, known as hypoglycemia.
Results from the study were presented at the 46th annual meeting of the European Association for the Study of Diabetes.
NACDS praises organized retail crime bill
ALEXANDRIA, Va. A bipartisan legislation that seeks to prevent organized retail crime is being applauded by the chain pharmacy industry.
The Organized Retail Theft Investigation and Prosecution Act of 2010, introduced by Reps. Bobby Scott, D-Va., and Lamar Smith, R-Texas, would create a specific task force within the Department of Justice to investigate and prosecute instances involving organized retail crime.
Responding to this proposed legislation, the National Association of Chain Drug Stores commended Reps. Scott and Smith for their leadership to curb the growing problem of organized retail crime, noting that retailers not only face such burdens as increased costs and investment to cover their losses, but consumers also face risks.
“Consumers are placed at risk when package tampering occurs on consumer healthcare products, such as infant formula and over-the-counter medications. These stolen products are repackaged and relabeled to falsely extend a product’s expiration date or to hide the fact that the item has been stolen,” NACDS wrote in a letter. The NACDS also urged Congress to support legislation that treats theft committed by organized, professional crime rings as a federal felony.
“We commend you again for introducing and advancing strong bipartisan legislation that will assist retailers and law enforcement to combat the serious problem of organized retail crime, and we look forward to working with you to enact this important legislation,” the letter stated.
NCPA supports drug disposal bills, makes approval recommendations
ALEXANDRIA, Va. A group representing the nation’s independent pharmacies heralded two pieces of legislation that pertain to the safe disposal of prescription drugs.
The National Community Pharmacists Association announced its support of legislative efforts made by the House of Representatives and the Senate, which passed their respective drug disposal bills Wednesday and last month. NCPA also added that it was “a giant step forward to allow for controlled substances, which had previously been precluded from any disposal programs, to be included.”
The lobbying group did, however, express concern that neither bill passed by the legislative bodies will provide liability protections for participating pharmacies nor adequate funding mechanisms or grant programs to assist in the cost of responsible collection. These concerns were conveyed to the House prior to the vote, NCPA said.
“Independent community pharmacists are uniquely positioned to help Americans get rid of expired and unused prescription drugs,” said Joseph Harmison, NCPA president and pharmacy owner. “That’s why over 1,000 member pharmacies are now engaged in a successful drug disposal programs with Sharps Compliance Inc.”